NCT03334045

Brief Summary

INTRODUCTION: Stress is one of the greatest burdens of our society and often imply impairments in cognitive and emotional functions. The investigators hypothesize that changes in the brain's dopamine(DA)-based mesocorticolimbic projections in patients with work-related stress (adjustment disorder) will manifest in altered glucose metabolism in relation to neural activity and altered DA radiotracer binding potential at neurotransmitter and receptor level. MATERIAL AND METHODS: Subjects and healthy controls undergo neuropsychiatric tests and PET/MR imaging with three tracers: \[18F\]FDG to measure glucose metabolism as a marker of neural activity, \[11C\]raclopride to investigate the DA binding potential in the striatum, and \[11C\]FLB 457 to study possible impaired mesocortical dopaminergic transmission. To demonstrate difference in glucose metabolism ≥2x41 patients/controls are needed. OUTCOME: The investigators expect to find that symptoms of cognitive and motivational/reward deficits could be attributable to changes in frontal lobe and striatal glucose metabolism in \>50% of patients and that changes in striatal D2 receptors and impaired mesocortical dopaminergic transmission in the prefrontal cortex are contributing factors. CONCLUSION: This project aims to generate entirely new and objective evidence of stress-induced cerebral illness and provide a basis for in depth research and more rational management of this strenuous disorder.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
82

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started May 2018

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 13, 2017

Completed
25 days until next milestone

First Posted

Study publicly available on registry

November 7, 2017

Completed
6 months until next milestone

Study Start

First participant enrolled

May 1, 2018

Completed
4.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2023

Completed
Last Updated

September 23, 2022

Status Verified

September 1, 2022

Enrollment Period

4.8 years

First QC Date

October 13, 2017

Last Update Submit

September 22, 2022

Conditions

Keywords

NeurobiologyOccupational StressDopamine

Outcome Measures

Primary Outcomes (1)

  • Glucose metabolism

    PET/MR scan

    3 year

Secondary Outcomes (1)

  • Dopamine binding potential

    3-4 years

Study Arms (2)

Stress patients

Patients diagnosed with work-related Adjustment disorder

Radiation: PET/MR scans

Controls

Healthy controls

Radiation: PET/MR scans

Interventions

PET/MR scansRADIATION

Observations of glucose metabolism and dopamine binding potential

ControlsStress patients

Eligibility Criteria

Age18 Years - 64 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

The patients are recruited among women aged 18-64 years.

You may qualify if:

  • Population and controls:
  • Informed consent before study-related activity
  • Aged 18 - 64
  • Labour market suitability
  • Study population:
  • Patients: F43.2

You may not qualify if:

  • Population, patients and controls:
  • Comorbid diagnoses as for instance: cancer, cardiovascular disease, diabetes.
  • Regular medication known to affect the central nervous system.
  • Prior exposure to violence and other serious harassment in the workplace
  • Psychosocial challenge in private life according to the screening criteria in the protocol.
  • Other serious illness
  • Metal in body
  • Claustrophobia
  • Pregnancy
  • Confounding drug consumption
  • Dependence e.g. alcohol, narcotics or other
  • Persons within a period of 1 year have participated in scientific studies that use isotopes, or who have had greater diagnostic tests that utilize ionizing radiation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Odense University Hospital

Odense, 5000, Denmark

Location

Related Publications (1)

  • Madsen SS, Gjedde A, Brandt L, Pihl-Thingvad J, Videbech P, Gerke O, Hojlund-Carlsen PF. Neurobiological effects of work-related stress: protocol for a case-control neuroimaging study. Dan Med J. 2018 Nov;65(11):A5513.

MeSH Terms

Conditions

Occupational Stress

Condition Hierarchy (Ancestors)

Occupational DiseasesStress, PsychologicalBehavioral SymptomsBehavior

Study Officials

  • Saga Steinmann Madsen, Engineering

    OUH

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
OTHER
Target Duration
2 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Engineer

Study Record Dates

First Submitted

October 13, 2017

First Posted

November 7, 2017

Study Start

May 1, 2018

Primary Completion

March 1, 2023

Study Completion

March 1, 2023

Last Updated

September 23, 2022

Record last verified: 2022-09

Data Sharing

IPD Sharing
Will not share

Locations